Combination of radiotherapy with EGFR antagonists for head and neck carcinoma. - Wikidata - wikimedia - TriplyDB

Combination of radiotherapy with EGFR antagonists for head and neck carcinoma.

Combination of radiotherapy with EGFR antagonists for head and neck carcinoma.

http://www.wikidata.org/entity/Q36795322

about

Epidermal growth factor receptor is a co-receptor for adeno-associated virus serotype 6.Interleukin 4, interleukin 6 and osteopontin-serological markers of head and neck malignancy in primary diagnostics: A pilot study Inhibition of radiation induced migration of human head and neck squamous cell carcinoma cells by blocking of EGF receptor pathways.Pre-clinical characterization of Dacomitinib (PF-00299804), an irreversible pan-ErbB inhibitor, combined with ionizing radiation for head and neck squamous cell carcinoma.Activated epidermal growth factor receptor in ovarian cancer.Increase in thiol oxidative stress via glutathione reductase inhibition as a novel approach to enhance cancer sensitivity to X-ray irradiation Comparison of radiosensitizing effects of the mammalian target of rapamycin inhibitor CCI-779 to cisplatin in experimental models of head and neck squamous cell carcinoma.The role of apoptosis in radiation oncology.Epidermal growth factor receptor as a therapeutic target in veterinary oncology.Differential proteomics in the search for biomarkers of radiotherapy resistance.Nuclear localization of Nm23-H1 in head and neck squamous cell carcinoma is associated with radiation resistance.Epidermal growth factor receptor activity is elevated in glioma cancer stem cells and is required to maintain chemotherapy and radiation resistance.

P2860

Q33913409-4212B491-7FDA-4BAE-8BC0-CDFC66C5E00F Q33967476-408ED901-F99D-4BD1-AF6D-799426F8FA11 Q34012333-FC15F7D7-EF0D-4C80-860D-04FB726570D5 Q35172674-6B841A1E-1510-470E-B3D6-8ADD566F3BA7 Q36981918-47068DE3-4BCB-410B-BC0E-3BB481E699F1 Q37350282-1AA79895-0816-43F5-82FE-676B06699106 Q37379788-A9E1C7A1-6CC5-48FD-95FD-A1882D863142 Q37413111-DA81EEA9-A87C-46FD-823F-2475307299FD Q37875223-020B06FC-47B8-45DC-8BE8-D3BFC2E9D2CA Q37912208-5F70922F-682F-4E87-8C65-FC4A8942F689 Q39555307-C1D4B315-1407-4695-A325-A418BD550F6A Q42700778-9CABBCEE-4FAD-4981-A644-D25385D15330

P2860

Combination of radiotherapy with EGFR antagonists for head and neck carcinoma.

http://www.wikidata.org/entity/Q36795322

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Combination of radiotherapy with EGFR antagonists for head and neck carcinoma.

@ast

Combination of radiotherapy with EGFR antagonists for head and neck carcinoma.

@en

type

label

Combination of radiotherapy with EGFR antagonists for head and neck carcinoma.

@ast

Combination of radiotherapy with EGFR antagonists for head and neck carcinoma.

@en

prefLabel

Combination of radiotherapy with EGFR antagonists for head and neck carcinoma.

@ast

Combination of radiotherapy with EGFR antagonists for head and neck carcinoma.

@en

P1433

Q36795322-95388CF2-77B1-405E-BC2C-F5E2C91BD219

P1476

Q36795322-1927084A-DAA9-45FF-B600-1331DC4CA37D

P2093

Q36795322-0F6694E0-C00F-4634-B844-50428C5B5221

Q36795322-5245DDC4-87B9-4DB4-8C68-8F04425FEDCB

Q36795322-654C84F9-9896-40A7-AAB4-DC218B654169

Q36795322-85E82C18-0839-4E5C-8376-D09FC988038E

Q36795322-9FF6CD87-C55E-49A2-B7A7-DC90C7D52E5D

P2860

Q36795322-7D6984B7-6E94-4A76-8BDD-A1B071A88DB0

Q36795322-A1F7B817-259F-4692-BD79-DCC6C6E5C974

Q36795322-F97D510E-823E-4F01-882A-84000F64C45F

Q36795322-FC2DCEC5-24C4-4EC3-A079-E49B68FC7FF4

P2888

Q36795322-9BA46AA1-4FEC-4B36-9D09-738331BAC7AB

P304

Q36795322-F5C6A42C-879E-4B17-A337-5462D60AE083

P31

Q36795322-80A0A505-45C7-4926-9BC0-C43470B0DB5A

P356

Q36795322-F2A50568-A336-4D63-9481-AB8D9AC33C54

P433

Q36795322-B614FBF9-54FF-49ED-8456-30EAA84ECA99

P478

Q36795322-B147156A-5D7C-47B2-B6BD-9774FBD3382B

P50

Q36795322-15EB92A5-BD43-48D0-B480-FA2A81BB9356

P577

Q36795322-246A6A7D-365A-4AA0-98FB-11CA023DFC82

P698

Q36795322-36E04EED-F7D1-4DF0-8DF0-3CF245106D53

P356

S10147-006-0663-5

P1433

International Journal of Clinical Oncology

P1476

Combination of radiotherapy with EGFR antagonists for head and neck carcinoma.

@en

P2093

Adam S Garden

http://www.w3.org/2001/XMLSchema#string

Gokcen Yildirim

http://www.w3.org/2001/XMLSchema#string

K Kian Ang

http://www.w3.org/2001/XMLSchema#string

Kathryn A Mason

http://www.w3.org/2001/XMLSchema#string

Luka Milas

http://www.w3.org/2001/XMLSchema#string

P2860

Early phase I data on an irreversible pan-erb inhibitor: CI-1033. What did we learn?

Phase II data with ZD6474, a small-molecule kinase inhibitor of epidermal growth factor receptor and vascular endothelial growth factor receptor, in previously treated advanced non-small-cell lung cancer.

Radiation-induced release of transforming growth factor alpha activates the epidermal growth factor receptor and mitogen-activated protein kinase pathway in carcinoma cells, leading to increased proliferation and protection from radiation-induced ce

Importance of maintenance therapy in C225-induced enhancement of tumor control by fractionated radiation.

P2888

s10147-006-0663-5

P304

99-110

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10147-006-0663-5

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Juliette Thariat

P577

2007-04-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17443277

http://www.w3.org/2001/XMLSchema#string